Literature DB >> 33952302

Correction to: Immunomodulatory effects of a new whole ingredients extract from Astragalus: a combined evaluation on chemistry and pharmacology.

Zhi Xin Li1, Guan Ding Zhao1, Wei Xiong1, Ke Gang Linghu1, Qiu Shuo Ma1, Wai San Cheang1, Hua Yu2,3,4,5, Yitao Wang6,7.   

Abstract

Entities:  

Year:  2021        PMID: 33952302      PMCID: PMC8101214          DOI: 10.1186/s13020-021-00440-3

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


× No keyword cloud information.

Correction to: Chin Med (2019) 14:12 10.1186/s13020-019-0234-0

Following the publication of the original article [1], it was noted that Table 1 is missing.
Table 1

Extraction amounts (g/100 g herb) of main compounds in different Astragalus extracts

ExtractTotal polysaccharides (g/100 g herb)Saponin (g/100 g herb)Flavonoid (g/100 g herb)
TotalAstra IVF IF IIF IIIIF IV
WIE12.87 ± 0.0320.52 ± 0.0220.011 ± 0.0010.010 ± 0.0020.003 ± 0.0010.039 ± 0.0010.013 ± 0.001
WAE11.52 ± 0.0270.25 ± 0.0190.012 ± 0.0010.004 ± 0.0010.001 ± 0.0010.019 ± 0.0030.004 ± 0.001

Astra IV Astragaloside IV, FI calycosin-7-O-β-d-glucoside, FII ononin; FIII calycosin; and FIV formononetin

WIE whole ingredients extract, WAE water extract

Extraction amounts (g/100 g herb) of main compounds in different Astragalus extracts Astra IV Astragaloside IV, FI calycosin-7-O-β-d-glucoside, FII ononin; FIII calycosin; and FIV formononetin WIE whole ingredients extract, WAE water extract The table and caption have been included in this correction, and the original article has been corrected.
  1 in total

1.  Immunomodulatory effects of a new whole ingredients extract from Astragalus: a combined evaluation on chemistry and pharmacology.

Authors:  Zhi Xin Li; Guan Ding Zhao; Wei Xiong; Ke Gang Linghu; Qiu Shuo Ma; Wai San Cheang; Hua Yu; Yitao Wang
Journal:  Chin Med       Date:  2019-03-27       Impact factor: 5.455

  1 in total
  1 in total

Review 1.  Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review.

Authors:  Yadong Fan; Ying Wang; Shuang Yu; Jun Chang; Yiqi Yan; Yiyang Wang; Yuhong Bian
Journal:  Chin Med       Date:  2021-07-28       Impact factor: 5.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.